MediPharm Labs Appoints Former Johnson & Johnson Group Product Director as Chief Strategy Officer
April 29, 2019 08:01 ET
|
MediPharm Labs Corp.
TORONTO, April 29, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis...
Stem Holdings, Inc. Announces Closing of the Previously Announced Acquisition of Western Coast Ventures, Inc.
April 12, 2019 17:46 ET
|
Stem Holdings, Inc
BOCA RATON, April 12, 2019 (GLOBE NEWSWIRE) -- Stem Holdings, Inc. (OTCQB: STMH CSE: STEM) (the “Company” or “Stem”) is pleased to announce it has now closed its previously announced acquisition...
MediPharm Labs Assembles Globally Renowned Experts to Form Scientific Advisory Committee
April 08, 2019 07:59 ET
|
MediPharm Labs Corp.
TORONTO, April 08, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis...
Emerald Health Therapeutics Receives Standard Processing License for Verdélite Facility in Quebec
April 08, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, April 08, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that its Québec facility, Verdélite, has...
Stem Holdings, Inc. Announces Closing of the Previously Announced Acquisition of South African Ventures, Inc.
April 01, 2019 08:00 ET
|
Stem Holdings, Inc
BOCA RATON, April 01, 2019 (GLOBE NEWSWIRE) -- Stem Holdings, Inc. (OTCQB: STMH CSE: STEM) (the “Company” or “Stem”) is pleased to announce it has now closed its previously announced acquisition...
World Class Announces Revenue Collaboration Agreement With Parity for Extraction in North Carolina and Potentially Other US States
March 25, 2019 07:00 ET
|
World Class Extractions Inc.
TORONTO, March 25, 2019 (GLOBE NEWSWIRE) -- World Class Extractions Inc. (CSE: PUMP) (the “Company” or “World Class”) is pleased to announce that it has signed a definitive collaboration agreement...
MediPharm Labs Announces Listing on Frankfurt Stock Exchange
February 19, 2019 09:04 ET
|
MediPharm Labs Corp.
TORONTO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE:MLZ) (“MediPharm”) a leader in specialized, research-driven cannabis extraction, distillation,...
MediPharm Labs Announces Listing on Frankfurt Stock Exchange
February 19, 2019 08:20 ET
|
MediPharm Labs Corp.
TORONTO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE:MLZ) (“MediPharm”) a leader in specialized, research-driven cannabis extraction, distillation,...
MediPharm Labs Signs $35 Million Private Label Cannabis Oil Sale Agreement with Option for Additional $13.5 Million
February 12, 2019 06:30 ET
|
MediPharm Labs Corp.
TORONTO, Feb. 12, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (“MediPharm”) a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is...
MediPharm Labs Aligns Leadership and Organizational Structure For Future Prosperity of Company
February 05, 2019 07:45 ET
|
MediPharm Labs Corp.
TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (the “Company” or “MediPharm Labs”) the leader in specialized, research-driven cannabis extraction, is...